Shares

21 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2022

Nov 14, 2022

SELL
$0.43 - $5.9 $15,529 - $213,084
-36,116 Reduced 8.1%
409,558 $237,000
Q2 2022

Aug 15, 2022

BUY
$0.38 - $0.64 $27,424 - $46,188
72,170 Added 19.32%
445,674 $213,000
Q1 2022

May 16, 2022

BUY
$0.55 - $0.98 $69,106 - $123,136
125,649 Added 50.69%
373,504 $250,000
Q4 2021

Feb 14, 2022

BUY
$0.9 - $1.31 $223,069 - $324,690
247,855 New
247,855 $244,000
Q3 2021

Nov 15, 2021

SELL
$1.21 - $1.61 $91,960 - $122,360
-76,000 Closed
0 $0
Q2 2021

Aug 16, 2021

SELL
$1.6 - $2.02 $824,464 - $1.04 Million
-515,290 Reduced 87.15%
76,000 $124,000
Q1 2021

May 17, 2021

BUY
$1.86 - $2.87 $610,548 - $942,083
328,252 Added 124.79%
591,290 $1.17 Million
Q4 2020

Feb 16, 2021

SELL
$1.65 - $2.43 $165,245 - $243,362
-100,149 Reduced 27.58%
263,038 $544,000
Q3 2020

Nov 16, 2020

SELL
$1.6 - $2.35 $830,347 - $1.22 Million
-518,967 Reduced 58.83%
363,187 $621,000
Q2 2020

Aug 14, 2020

SELL
$1.33 - $2.76 $168,385 - $349,432
-126,606 Reduced 12.55%
882,154 $2.05 Million
Q1 2020

May 15, 2020

BUY
$0.97 - $2.85 $185,067 - $543,754
190,791 Added 23.32%
1,008,760 $1.56 Million
Q4 2019

Feb 14, 2020

BUY
$1.69 - $3.8 $947,591 - $2.13 Million
560,705 Added 217.95%
817,969 $3.11 Million
Q3 2019

Nov 14, 2019

BUY
$0.61 - $2.21 $89,229 - $323,274
146,278 Added 131.8%
257,264 $473,000
Q2 2019

Aug 14, 2019

SELL
$0.51 - $0.86 $9,537 - $16,082
-18,700 Reduced 14.42%
110,986 $72,000
Q1 2019

May 15, 2019

BUY
$0.51 - $0.82 $2,841 - $4,569
5,572 Added 4.49%
129,686 $81,000
Q4 2018

Feb 14, 2019

BUY
$0.48 - $1.1 $3,213 - $7,364
6,695 Added 5.7%
124,114 $60,000
Q3 2018

Nov 14, 2018

BUY
$1.06 - $1.69 $52,248 - $83,301
49,291 Added 72.35%
117,419 $129,000
Q2 2018

Aug 14, 2018

SELL
$1.56 - $2.51 $276,371 - $444,674
-177,161 Reduced 72.23%
68,128 $106,000
Q1 2018

May 15, 2018

BUY
$0.91 - $2.24 $135,151 - $332,680
148,518 Added 153.47%
245,289 $525,000
Q4 2017

Feb 14, 2018

BUY
$0.78 - $2.1 $14,256 - $38,383
18,278 Added 23.29%
96,771 $89,000
Q3 2017

Nov 14, 2017

BUY
$1.55 - $1.82 $121,664 - $142,857
78,493
78,493 $139,000

Others Institutions Holding DRRX

About DURECT CORP


  • Ticker DRRX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 227,794,000
  • Market Cap $173M
  • Description
  • DURECT Corporation, a biopharmaceutical company, researches and develops medicines based on its epigenetic regulator and pharmaceutical programs. The company offers ALZET product line that consists of osmotic pumps and accessories used for research in mice, rats, and other laboratory animals. It also develops larsucosterol (DUR-928), an endogeno...
More about DRRX
Track This Portfolio

Track Two Sigma Investments, LP Portfolio

Follow Two Sigma Investments, LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Two Sigma Investments, LP, based on Form 13F filings with the SEC.

News

Stay updated on Two Sigma Investments, LP with notifications on news.